Treatment of Typhoid Fever
First-Line Treatment Recommendation
Azithromycin 500 mg once daily for 7 days is the preferred first-line treatment for typhoid fever in adults, particularly for cases originating from South Asia where fluoroquinolone resistance exceeds 70%. 1, 2
For children, azithromycin should be dosed at 20 mg/kg/day (maximum 1g/day) for 7 days. 1, 2
Treatment Algorithm Based on Geographic Origin and Severity
For Uncomplicated Cases from South Asia or Unknown Origin
- Start with oral azithromycin as empiric therapy due to fluoroquinolone resistance rates approaching 96% in some South Asian regions. 1
- Azithromycin demonstrates superior outcomes with lower risk of clinical failure (OR 0.48) compared to fluoroquinolones. 1, 2
- Hospital stays are approximately 1 day shorter with azithromycin compared to fluoroquinolones (MD -1.04 days). 1
- Relapse risk is dramatically lower with azithromycin (OR 0.09) compared to ceftriaxone. 1, 2
For Severe Cases or Unstable Patients
- Initiate IV ceftriaxone 2g daily for adults (or 50-80 mg/kg/day, maximum 2g/day for children) for patients with sepsis features or severe illness. 3, 2
- Continue ceftriaxone for 14 days to reduce relapse risk. 3
- Transition to oral therapy when clinically improved. 2
- Alternative dosing: 1-2g IV/IM daily for 5-7 days in adults has been used successfully in some studies. 1
For Confirmed Susceptible Isolates
- Fluoroquinolones (ciprofloxacin or ofloxacin) remain effective when susceptibility is confirmed by testing. 1, 2
- Critical caveat: Ciprofloxacin disc testing alone is unreliable; the organism must also be sensitive to nalidixic acid on disc testing to be considered truly fluoroquinolone-sensitive. 3
- The FDA approves ciprofloxacin for typhoid fever caused by Salmonella typhi. 4
Critical Diagnostic Steps Before Treatment
- Obtain blood cultures before starting antibiotics whenever possible, as they have the highest yield (40-80% sensitivity) within the first week of symptom onset. 1, 3
- For patients with sepsis features, start broad-spectrum antimicrobial therapy immediately after collecting blood, stool, and urine cultures. 1, 2
- Bone marrow cultures have higher sensitivity than blood cultures but are rarely practical. 3
- The serological Widal test lacks sensitivity and specificity and is not recommended. 3
Monitoring and Expected Clinical Response
- Expect fever clearance within 4-5 days of appropriate therapy. 1, 2
- If no clinical response by day 5, consider antimicrobial resistance or alternative diagnosis. 1
- Mean defervescence time with ceftriaxone is approximately 4-5 days. 5, 6
- Complete the full 7-day course (for azithromycin) or 14-day course (for ceftriaxone) to prevent relapse, which occurs in 10-15% of inadequately treated cases. 1, 3
Common Pitfalls to Avoid
- Never use ciprofloxacin empirically for cases from South or Southeast Asia due to widespread resistance exceeding 70%. 1, 3, 2
- Do not use cefixime as first-line therapy: it has documented treatment failure rates of 4-37.6% and relapse rates of 4-37.6%. 1
- If cefixime must be used, a mandatory test-of-cure at 1 week is required due to high failure rates. 1
- The WHO lists cefixime only as an "alternative" option, not first-line. 1
- Do not discontinue antibiotics prematurely even if fever resolves early. 1
- Avoid combination typhoid-paratyphoid vaccines; only monovalent S. typhi preparations should be used. 1
Management of Complications
- Complications occur in 10-15% of patients with illness duration exceeding 2 weeks, including gastrointestinal bleeding, intestinal perforation, and typhoid encephalopathy. 1, 3
- Intestinal perforation requires surgical intervention with simple excision and closure, reported successful in up to 88.2% of cases. 1
Adverse Effects and Drug Interactions
- Common azithromycin adverse effects include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea. 1, 2
- Monitor for potential drug interactions with azithromycin, particularly QT-prolonging medications. 1, 2
Specific Dosing Summary
Azithromycin (First-Line):
Ceftriaxone (Severe Cases or Alternative):
- Adults: 2g IV daily for 14 days 3 or 1-2g IV/IM daily for 5-7 days 1
- Children: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 1
Fluoroquinolones (Only for Confirmed Susceptible Isolates):
- Use only when susceptibility confirmed by both ciprofloxacin and nalidixic acid disc testing 3
- Avoid empirically for South Asian cases 1, 3, 2
Prevention Considerations
- Typhoid vaccination is recommended for travelers to endemic areas, particularly Latin America, Asia, and Africa. 1, 3, 2
- Vaccination provides incomplete protection (does not protect against paratyphoid) and should not replace food and water safety precautions. 1, 3, 2
- Hand hygiene and appropriate food safety practices remain essential. 1